***
		***
		***

two phase III clinical development programs underway to evaluate CellCept; an orally delivered immunosuppressant agent; in the treatment of the autoimmune diseases; such as lupus nephritis and pemphigus vulgaris

  Korean Distributor : ???

  Products information :

• ### → ###